A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China

PHASE4RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 8, 2023

Primary Completion Date

July 31, 2030

Study Completion Date

July 31, 2030

Conditions
Open-angle GlaucomaOAG
Interventions
DEVICE

XEN45 Glaucoma Treatment System

Ab interno implantation

PROCEDURE

Trabeculectomy

Surgical Intervention

Trial Locations (12)

100044

RECRUITING

Peking University people s hospital /ID# 265493, Beijing

100191

RECRUITING

Peking University Third Hospital /ID# 243994, Beijing

100730

RECRUITING

Beijing Tongren Hospital Affiliated To Capital Medical University /ID# 244055, Beijing

266071

RECRUITING

Qingdao Eye Hospital Of Shandong First Medical University /ID# 243992, Qingdao

300070

RECRUITING

Tianjin Eye Hospital /ID# 243997, Tianjin

310009

RECRUITING

The Second Affiliated Hospital of Zhejiang University School of Medicine /ID# 243996, Hangzhou

350005

RECRUITING

The First Affiliated Hospital Of Fujian Medical University /ID# 244004, Fuzhou

390000

COMPLETED

Xiamen Eye Center of Xiamen University /ID# 244000, Xiamen

430030

RECRUITING

Tongji Hospital Tongji Medical College of HUST /ID# 243998, Wuhan

510623

RECRUITING

Zhongshan Ophthalmic Center,SunYat-Sen University /ID# 243843, Guangzhou

518034

RECRUITING

Shenzhen Eye Hospital /ID# 244001, Shenzhen

610041

RECRUITING

West China Hospital, Sichuan University /ID# 243999, Chengdu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY